As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis.
The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s Disease appeared first on MedCity News.
